GREAT NEWS! It was just announced that the Myeloma Institute received a $10 million dollar gift from Celgene Corporation to benefit patients with multiple myeloma through the creation of The Bart Barlogie Center for Molecular Diagnostics and the establishment of the Celgene Distinguished Endowed Chair in Molecular Therapeutics.

UAMS Chancellor Dr. Dan Rhan, Myeloma Institute Director Dr. Gareth Morgan, Myeloma Institute Founder Dr. Bart Barlogie, and Arkansas Governor Asa Hutchinson and others were on hand during today’s announcement. Read the Press Release.

Since 1989, our mission has been guided by one enduring principle: CURE.  UAMS Myeloma Institute for Research and Therapy is a world leader in multiple myeloma research and treatment. Our team of dynamic scientists and clinicians translates advances from the laboratory into novel clinical treatments, continually expanding the boundaries of myeloma research and therapy toward cure for all patients. The Myeloma Institute has pioneered many breakthrough developments and discoveries. Read more about our significant firsts.

What is Multiple Myeloma?

What is Myeloma?

 

 

 

Learn about myeloma biology, symptoms, diagnosis and more.

 

What Patients Say About Us

What Patients Say About Us

 

 

 

The Myeloma Institute has one of the highest volumes of multiple myeloma patients in the world. Our patients have great things to say about us.

 

About Little Rock/Travel

Little Rock

 

 

 

Little Rock is the capital and largest city in Arkansas, as well as the state center for business, healthcare and culture. Discover more about Little Rock, including information on travel, lodging, and dining.

 

New and Noteworthy

New and Noteworthy-Myeloma Briefing

 

 

 

 

Read up on the latest Myeloma Institute news, publications and interesting cases.